The PE Ratio as of December 2025 (TTM) for Tibet Weixinkang Medicine Co., Ltd. (603676.SS) is 21.12

According to Tibet Weixinkang Medicine Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 21.12. This represents a change of -80.07% compared to the average of 106.00 of the last 4 quarters.

Tibet Weixinkang Medicine Co., Ltd. (603676.SS) Historical PE Ratio (quarterly & annually)

How has 603676.SS PE Ratio performed in the past?

The mean historical PE Ratio of Tibet Weixinkang Medicine Co., Ltd. over the last ten years is 43.00. The current 21.12 PE Ratio has changed 4.81% with respect to the historical average. Over the past ten years (40 quarters), 603676.SS's PE Ratio was at its highest in in the December 2024 quarter at 366.12. The PE Ratio was at its lowest in in the March 2024 quarter at 9.81.

Tibet Weixinkang Medicine Co., Ltd. (603676.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Tibet Weixinkang Medicine Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tibet Weixinkang Medicine Co., Ltd. (603676.SS) Average PE Ratio

How has 603676.SS PE Ratio performed in the past?

The current PE Ratio of Tibet Weixinkang Medicine Co., Ltd. (603676.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tibet Weixinkang Medicine Co., Ltd. (603676.SS) PE Ratio vs. Peers

How is 603676.SS’s PE Ratio compared to its peers?

Tibet Weixinkang Medicine Co., Ltd.’s PE Ratio is greater than Yabao Pharmaceutical Group Co., Ltd (20.83), greater than Hunan Fangsheng Pharmaceutical Co., Ltd. (16.99), greater than ZhuZhou QianJin Pharmaceutical Co.,Ltd (17.51), less than Jinhe Biotechnology Co. Ltd. (36.43), greater than Wuhan Hiteck Biological Pharma Co.,Ltd (-19.76), less than HPGC Renmintongtai Pharmaceutical Corporation (57.38), greater than Tianjin Lisheng Pharmaceutical Co.,Ltd. (13.74), less than Beijing Beilu Pharmaceutical Co., Ltd (128.21), greater than Zhejiang Starry Pharmaceutical Co.,Ltd. (-141.79), less than Ningbo Menovo Pharmaceutical Co., Ltd. (42.66),

Build a custom stock screener for Tibet Weixinkang Medicine Co., Ltd. (603676.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tibet Weixinkang Medicine Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tibet Weixinkang Medicine Co., Ltd. (603676.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tibet Weixinkang Medicine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.